Table 3.
Outcome | Prevalence in screening group | Prevalence in COVID-19 group | Sample size screening group | Sample size COVID-19 group |
Pre-eclampsia | 6% | 12% | 511 | 256 |
Thrombosis | 0.13% | 2% | 613 | 306 |
Small for gestational age (below 10th percentile) | 10% | 20% | 199 | 199 |
Preterm delivery | 6% | 12% | 511 | 256 |
Neurological and/or neurodevelopmental disorders | 1% | 4% | 581 | 290 |